Iridex (IRIX) Cash from Investing Activities (QoQ) (2011 - 2026)
Iridex (IRIX) Cash from Investing Activities (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn |
| 10 | Iridex | 13.40 Mn | 8.72 Mn | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 4.72% |
| Jan 3, 2026 | -715.38% |
| Sep 27, 2025 | 0.00% |
| Jun 28, 2025 | -18.18% |
| Mar 29, 2025 | -22.22% |
| Dec 28, 2024 | -800.00% |
| Mar 30, 2024 | -109.38% |
| Dec 30, 2023 | 139.02% |
| Sep 30, 2023 | -412.50% |
| Jul 1, 2023 | 62.79% |
| Apr 1, 2023 | 48.19% |
| Dec 31, 2022 | -45.61% |
| Oct 1, 2022 | 52.50% |
| Jul 2, 2022 | -361.54% |
| Apr 2, 2022 | 99.52% |
| Sep 26, 2020 | 54.55% |
| Jun 27, 2020 | 83.82% |
| Mar 28, 2020 | -3.03% |
| Dec 28, 2019 | 50.38% |
| Sep 28, 2019 | 9.52% |